Cyril Amarchand Mangaldas (CAM), Khaitan & Co and Shardul Amarchand Mangaldas & Co (SAM) advised on Sahajanand Medical Technologies’ IPO.
Sahajanand Medical Technologies Limited, a medical devices company with a presence across 65 countries, undertook an initial public offering (IPO) that included an offer for sale by existing shareholders, including Samara Capital Markets Holding, Kotak Pre-IPO Opportunities Fund, NHPEA Sparkle Holding (Morgan Stanley Group) and certain promoter group selling shareholders.
CAM served as the primary legal counsel advising Sahajanand Medical Technologies Limited.
Khaitan & Co advised the book-running lead managers — Motilal Oswal Investment Advisors Limited, Avendus Capital, HSBC Securities and Capital Markets and Nuvama Wealth Management on the IPO.
The deal team comprised Chirayu Chandani, Tishita Mukherjee, Ira Pandya, Kaushlendra Singh Palawat, Aastha Dhuppad, Hrishi Kapadia and Harshita Sharma.
SAM acted as legal counsel to Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies, consisting of the sale of approximately 1.31% stake through an offer for sale in the IPO and a secondary transfer of approximately 1.15% through a pre-IPO placement.
The Capital Markets team comprised Partner Nikhil Naredi, Principal Associate Chinmay Sethia and Associate Shariba Tasneem.
The General Corporate team comprised Partner Nivedita Tiwari, Principal Associate Kuhuk Jain and Senior Associate Jasmine Khan.
